Characteristic | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | |
Age (< 59 years vs. ≥ 59) | 1.275 | 0.980–1.660 | 0.071 |  |  |  |
Gender (Male vs. Female) | 1.212 | 0.926–1.586 | 0.162 |  |  |  |
CRP, mg/L (≥ 3.26 vs. < 3.26) | 1.393 | 1.069–1.813 | 0.014 |  |  | 0.835 |
WBCs, ×109 (≥ 6.4 vs. < 6.4) | 1.194 | 0.918–1.552 | 0.186 |  |  |  |
Neutrophils, ×109 (≥ 3.9 vs. < 3.9) | 1.084 | 0.834–1.410 | 0.546 |  |  |  |
Platelets, ×109 (≥ 252 vs. < 252) | 2.013 | 1.543–2.626 | <0.001 | 1.563 | 1.151–2.124 | 0.004 |
ALB, g/L (≥ 40.5 vs. < 40.5) | 0.709 | 0.545–0.922 | 0.010 |  |  | 0.275 |
CA199, U/mL (≥ 27 vs. < 27) | 1.091 | 0.817–1.458 | 0.555 |  |  | 0.635 |
CEA, ng/mL (≥ 5 vs. < 5) | 1.504 | 1.154–1.959 | 0.003 | 1.819 | 1.350–2.450 | <0.001 |
T lymphocytes, ×109 (≥1.6vs. < 1.6) | 0.894 | 0.688–1.163 | 0.404 |  |  |  |
Monocytes, ×109 (≥ 0.4 vs. < 0.4) | 0.987 | 0.759–1.284 | 0.923 |  |  |  |
MMR, (P vs. D) | 0.303 | 0.207–0.441 | <0.001 | 0.309 | 0.209–0.457 | <0.001 |
Chemotherapy | ||||||
 No | 1.220 | 0.911–1.634 | 0.182 |  |  |  |
 Yes | 1.252 | 0.932–1.681 | 0.135 |  |  |  |
 0.237 Unknown | 1.026 | 0.767–1.372 | 0.862 |  |  |  |
Radiotherapy | ||||||
 No | 1.234 | 0.920–1.655 | 0.160 |  |  |  |
 Yes | 1.235 | 0.871–1.750 | 0.237 |  |  |  |
 Unknown | 0.975 | 0.678–1.401 | 0.889 |  |  |  |
TNM | Â | Â | <0.001 | Â | Â | 0.001 |
 1 | 1.000 | 1.000 |  | 1.000 | 1.000 |  |
 2 | 3.483 | 1.903–6.375 | <0.001 | 3.126 | 1.665–5.869 | <0.001 |
 3 | 2.517 | 1.351–4.689 | 0.004 | 2.470 | 1.291–4.725 | 0.006 |
 4 | 2.452 | 1.310–4.590 | 0.005 | 2.345 | 1.217–4.516 | 0.011 |
PLR | 1.834 | 1.407–2.391 | <0.001 | 1.454 | 1.071–1.975 | 1.4540.022d |
NLR | 1.411 | 1.084–1.836 | 0.010 |  |  | 0.443 |
CAR | 1.482 | 1.137–1.930 | 0.004 |  |  | 0.428 |
PNI | 1.111 | 0.855–1.444 | 0.431 |  |  |  |
mGPS | Â | Â | 0.004 | Â | Â | 0.428 |
 0 | 1.000 | 1.000 |  |  |  |  |
 1 | 1.678 | 1.233–2.285 | 0.001 |  |  | 0.195 |
 2 | 1.313 | 0.859–2.008 | 0.208 |  |  | 0.850 |